COVID-19 of dialysis patients in Japan: Current status and guidance on preventive measures.

Published on Aug 1, 2020in Therapeutic Apheresis and Dialysis1.041
· DOI :10.1111/1744-9987.13531
Kan Kikuchi10
Estimated H-index: 10
,
Masaomi Nangaku80
Estimated H-index: 80
(UTokyo: University of Tokyo)
+ 8 AuthorsTadao Akizawa1
Estimated H-index: 1
(Memorial Hospital of South Bend)
Sources
Abstract
In Japan, the first case of COVID-19 in dialysis patients was reported on March 1, 2020. A total of 31 cases were reported by April 10, and it increased to 95 by May 15. Thereafter, with the rapid increase in the number of COVID-19 cases in the general population since late March, there was a not surprising increase in the number of COVID-19 cases in dialysis patients. The mortality rate is 16.2% (16/99 cases) in dialysis patients, which is higher than 5.3% (874/16532 cases) in the general population. This higher mortality rate in dialysis patients with COVID-19 might be related to their age; the majority of COVID-19 cases are aged between 70 and 90 years in dialysis patients, compared with between 20 and 60 years in the general population. As COVID-19 presents with severe symptoms and is associated with a high mortality rate in dialysis patients, dialysis patients who have contracted SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) testing are required to be hospitalized under Japanese government policy. In cases of COVID-19 hospitalizations, it is essential to prevent nosocomial infection. Therefore, patients must be sufficiently instructed in infection prevention and robust measures to prevent contraction and spread of the infection must be taken at dialysis facilities. This article is protected by copyright. All rights reserved.
📖 Papers frequently viewed together
2020
3 Authors (M. Nouvier, ..., Denis Fouque)
References10
Newest
#1Marian Goicoechea (ISCIII: Carlos III Health Institute)H-Index: 24
Last. Inés Aragoncillo (ISCIII: Carlos III Health Institute)H-Index: 9
view all 27 authors...
SARS-CoV-2-pneumonia emerged in Wuhan, China in December 2019. Unfortunately, there is lack of evidence about the optimal management of novel coronavirus disease 2019 (COVID-19), even less in patients on maintenance hemodialysis (MHD) therapy than in the general population. In this retrospective observational single-center study we analyzed the clinical course and outcomes of all MHD patients hospitalized with COVID-19 from March 12th to April 10th, 2020 as confirmed by real time polymerase chai...
98 CitationsSource
#1Federico Alberici (University of Brescia)H-Index: 21
#2Elisa DelbarbaH-Index: 6
Last. Francesco Scolari (University of Brescia)H-Index: 57
view all 31 authors...
Abstract The SARS-CoV-2 epidemic is pressuring health care systems worldwide. Disease outcomes in certain subgroups of patients are still scarce, and data are needed. Therefore, we describe here the experience of four dialysis centers of the Brescia Renal COVID task force. During March 2020, within an overall population of 643 hemodialysis patients, SARS-CoV-2 RNA positivity was detected in 94 (15%). At disease diagnosis, 37 of the 94 (39%) patients (group 1) were managed on an outpatient basis ...
72 CitationsSource
#1Safiya Richardson (Hofstra University)H-Index: 9
#2Jamie S. Hirsch (Hofstra University)H-Index: 13
Last. Theodoros P. ZanosH-Index: 15
view all 27 authors...
Importance: There is limited information describing the presenting characteristics and outcomes of US patients requiring hospitalization for coronavirus disease 2019 (COVID-19). Objective: To describe the clinical characteristics and outcomes of patients with COVID-19 hospitalized in a US health care system. Design, Setting, and Participants: Case series of patients with COVID-19 admitted to 12 hospitals in New York City, Long Island, and Westchester County, New York, within the Northwell Health...
3,234 CitationsSource
#1Annemarie B Docherty (Edin.: University of Edinburgh)H-Index: 19
#2Ewen M Harrison (Edin.: University of Edinburgh)H-Index: 33
Last. Isaric C InvestigatorsH-Index: 7
view all 25 authors...
Abstract Objective To characterise the clinical features of patients admitted to hospital with coronavirus disease 2019 (covid-19) in the United Kingdom during the growth phase of the first wave of this outbreak who were enrolled in the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) World Health Organization (WHO) Clinical Characterisation Protocol UK (CCP-UK) study, and to explore risk factors associated with mortality in hospital. Design Prospective observat...
950 CitationsSource
#1Xiaonan Zhang (Fudan University)H-Index: 24
#2Yun Tan (SJTU: Shanghai Jiao Tong University)H-Index: 8
Last. Hongzhou Lu (Fudan University)H-Index: 30
view all 25 authors...
In December 2019, the Coronavirus disease 2019 (COVID-19), caused by a novel coronavirus SARS-CoV-2, emerged in Wuhan, Hubei province, China1 and soon spread across the world. In this ongoing pandemic, public health concerns and the urgent need for effective therapeutic measures require a deep understanding of its epidemiology, transmissibility and pathogenesis. Here we analyzed the clinical, molecular and immunological data from 326 confirmed cases of COVID-19 in Shanghai. Genomic sequences of ...
292 CitationsSource
#1T. Alp Ikizler (Vandy: Vanderbilt University)H-Index: 90
Abstract The clinical presentation and mortality rate in maintenance hemodialysis (MHD) patients with COVID-19 are not well established. Recent data from Italy and Spain suggest that these patients present with wide range of symptoms, with a significant portion being asymptomatic. There is prolonged positivity of pharyngeal swabs in MHD patients. The mortality rates are very high, reaching almost 30%. These data highlight the importance of diligent oversight and care of MHD patients during COVID...
6 CitationsSource
Among the many surprises of the new coronavirus is one that seems to defy basic biology: infected patients with extraordinarily low blood oxygen levels, or hypoxia, scrolling through their phones, chatting with doctors, and generally describing themselves as comfortable. Clinicians call them the happy hypoxics. A normal blood oxygen saturation is at least 95%. In most lung diseases, such as pneumonia, falling saturations accompany other physiologic changes, including stiff or fluid-filled lungs,...
75 CitationsSource
#1Saraladevi Naicker (University of the Witwatersrand)H-Index: 28
#2Chih-Wei Yang (CGU: Chang Gung University)H-Index: 14
Last. Vivekanand Jha (UNSW: University of New South Wales)H-Index: 111
view all 6 authors...
247 CitationsSource
#1Ning Tang (HUST: Huazhong University of Science and Technology)H-Index: 7
#2Dengju Li (HUST: Huazhong University of Science and Technology)H-Index: 5
Last. Ziyong Sun (HUST: Huazhong University of Science and Technology)H-Index: 28
view all 4 authors...
Abstract Background In the recent outbreak of novel coronavirus infection in Wuhan, China, significantly abnormal coagulation parameters in severe novel coronavirus pneumonia (NCP) cases were a concern. Objectives To describe the coagulation feature of patients with NCP. Methods Conventional coagulation results and outcomes of consecutive 183 patients with confirmed NCP in Tongji hospital were retrospectively analysed. Results The overall mortality was 11.5%, the non-survivors revealed significa...
2,197 CitationsSource
#1David Harris (USYD: University of Sydney)H-Index: 75
#2Simon J. Davies (Keele University)H-Index: 55
Last. Ming-Hui ZhaoH-Index: 56
view all 95 authors...
The global nephrology community recognizes the need for a cohesive strategy to address the growing problem of end-stage kidney disease (ESKD). In March 2018, the International Society of Nephrology hosted a summit on integrated ESKD care, including 92 individuals from around the globe with diverse expertise and professional backgrounds. The attendees were from 41 countries, including 16 participants from 11 low- and lower-middle–income countries. The purpose was to develop a strategic plan to im...
56 CitationsSource
Cited By14
Newest
#1Yuka Sugawara (UTokyo: University of Tokyo)H-Index: 1
#2Masao Iwagami (Lond: University of London)H-Index: 9
Last. Masaomi Nangaku (UTokyo: University of Tokyo)H-Index: 80
view all 12 authors...
BACKGROUND: There are no reports of a large-scale survey on the infection prevention measures against coronavirus disease 2019 (COVID-19) in nephrology facilities. This study investigated the facility-level nephrology practices adopted during the COVID-19 pandemic and their associated challenges. Additionally, the treatment patterns and outcomes of chronic kidney disease (CKD) patients with COVID-19 were reviewed. METHODS: We conducted a nationwide questionnaire survey of 704 educational facilit...
Source
#1Bruce M. RobinsonH-Index: 30
#1Bruce M. RobinsonH-Index: 38
Last. Roberto Pecoits-Filho (PUCPR: Pontifícia Universidade Católica do Paraná)H-Index: 60
view all 19 authors...
As the worst global pandemic of the past century, COVID-19 has had a disproportionate effect on maintenance dialysis patients and their health care providers. At a virtual roundtable on 12 June 2020, DOPPS investigators from fifteen countries in Asia, Europe, and the Americas described and compared the effects of COVID-19 on dialysis care, with recent updates added. Most striking is the huge difference in risk to dialysis patients and staff across the world. Per-population cases and deaths among...
Source
Source
#1Kasumi Yoshinaga (Okayama University)H-Index: 1
#2Motoo ArakiH-Index: 17
view all 25 authors...
Abstract Case presentation. A 49-year-old Asian male, who had undergone hemodialysis for >16 years, complained of a fever, dysgeusia and dysosmia, and was diagnosed with COVID-19 pneumonia based on severe acute respiratory syndrome coronavirus 2 polymerase chain reaction (SARS-CoV-2 PCR) and computed tomography (CT). Treatment was started with oral favipiravir and ciclesonide inhalation. On the 10th day of treatment, the patient had a persistent high fever and a chest CT showed exacerbation of p...
Source
#1Caitlin Monaghan (Fresenius Medical Care)H-Index: 1
#2John W. Larkin (Fresenius Medical Care)H-Index: 5
Last. Franklin W. Maddux (Fresenius Medical Care)H-Index: 21
view all 16 authors...
Background: We developed a machine learning (ML) model that predicts the risk of a hemodialysis (HD) patient having an undetected SARS-CoV-2 infection that is identified after the following 3 or more days. Methods: As part of a healthcare operations effort we used patient data from a national network of dialysis clinics (February-September 2020) to develop a ML model (XGBoost) that uses 81 variables to predict the likelihood of an adult HD patient having an undetected SARS-CoV-2 infection that i...
1 CitationsSource
#1Mabel Aoun (""St. Joe's"": Saint Joseph's University)H-Index: 4
Last. Dania Chelala (""St. Joe's"": Saint Joseph's University)H-Index: 5
view all 52 authors...
Hemodialysis patients with COVID-19 have been reported to be at higher risk for death than the general population. Several prognostic factors have been identified in the studies from Asian, European or American countries. This is the first national Lebanese study assessing the factors associated with SARS-CoV-2 mortality in hemodialysis patients. This is an observational study that included all chronic hemodialysis patients in Lebanon who were tested positive for SARS-CoV-2 from 31st March to 1s...
Source
#1Leena TajiH-Index: 1
#2Doneal Thomas (U of T: University of Toronto)H-Index: 1
Last. Peter G. BlakeH-Index: 44
view all 10 authors...
Background: Patients undergoing longterm dialysis may be at higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and of associated disease and mortality. We aimed to describe the incidence, risk factors and outcomes for infection in these patients in Ontario, Canada. Methods: We used linked data sets to compare disease characteristics and mortality between patients receiving longterm dialysis in Ontario who were diagnosed SARS-CoV-2 positive and those who di...
5 CitationsSource
#1Rei IioH-Index: 1
#2Tetsuya KanekoH-Index: 13
Last. Yoshitaka Isaka (Osaka University)H-Index: 64
view all 4 authors...
BACKGROUND: Blood purification therapy is a treatment method, wherein many patients gather in the same space to receive regular treatments, possibly increasing the risk of contracting the coronavirus disease 2019 (COVID-19) through contact, droplet, and aerosol. We experienced a nosocomial outbreak and evaluated the clinical characteristics of COVID-19 infection in patients undergoing blood purification therapy. METHODS: We retrospectively analyzed 28 patients who underwent blood purification th...
Source
#1Yanglin Hu (HUST: Huazhong University of Science and Technology)
#2Can Tu (HUST: Huazhong University of Science and Technology)H-Index: 2
Last. Fei Xiong (HUST: Huazhong University of Science and Technology)H-Index: 3
view all 11 authors...
HD care may experience great stress with the coronavirus disease 2019 (COVID-19) pandemic. A modified HD modality named bed-sided short-duration renal replacement therapy (BSRRT) was used in noncritical maintenance HD (MHD) patients diagnosed with COVID-19 in Wuhan due to extreme situation. To determine the safety and efficacy as a substitution for intermittent HD (IHD), we conducted this study. We used the data of 88 noncritical COVID-19 MHD patients collected from 65 medical units at the hospi...
Source
#1Eri Koshi (Nagoya University)H-Index: 3
#2Shoji Saito (Nagoya University)H-Index: 5
Last. Shoichi Maruyama (Nagoya University)H-Index: 47
view all 17 authors...
Novel coronavirus disease 2019 (COVID-19) refers to infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, and has spread to pandemic levels since its inception in December 2019. While several risk factors for severe presentation have been identified, the clinical course for end-stage renal disease (ESRD) patients on maintenance hemodialysis with COVID-19 has been unclear. Previous studies have revealed that some antiviral agents may be effective against COVID-...
5 CitationsSource